Reconova Technologies Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	480.72	442.96	395.18	242.38
Revenue Growth	-	12.09%	63.05%	-
Cost of Revenue	300.99	275.86	237.95	143.55
Gross Profit	179.72	167.09	157.23	98.82
Selling, General & Admin	93.89	93.95	85.19	82.7
Research & Development	88.77	71.9	53.14	46.64
Other Operating Expenses	0.53	0.53	0.45	0.24
Operating Expenses	252.71	235.9	157.24	139.16
Operating Income	-72.99	-68.81	-0.01	-40.34
Interest Expense	-5.9	-4.99	-1.94	-1.39
Interest & Investment Income	0.01	0.01	0.13	0.24
Other Non Operating Income (Expenses)	4.39	5.62	10.15	8.33
EBT Excluding Unusual Items	-74.48	-68.17	8.33	-33.16
Gain (Loss) on Sale of Investments	0.01	0.01	0.01	0.37
Gain (Loss) on Sale of Assets	-0.38	-0.38	-0.05	0.22
Other Unusual Items	0.4	0.4	-	-
Pretax Income	-63.54	-68.15	8.29	-32.58
Earnings From Continuing Operations	-63.54	-68.15	8.29	-32.58
Minority Interest in Earnings	1.05	0.93	1.43	3.14
Net Income	-62.49	-67.22	9.71	-29.43
Net Income to Common	-62.49	-67.22	9.71	-29.43
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	276	274	273	273
Shares Outstanding (Diluted)	276	274	273	273
Shares Change	-	0.36%	-	-
EPS (Basic)	-0.23	-0.25	0.04	-0.11
EPS (Diluted)	-0.23	-0.25	0.04	-0.11
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-79.3	-126.58	11.14	-64.26
Free Cash Flow Per Share	-0.29	-0.46	0.04	-0.23
Gross Margin	37.39%	37.72%	39.79%	40.77%
Operating Margin	-15.18%	-15.53%	-0.00%	-16.64%
Profit Margin	-13.00%	-15.18%	2.46%	-12.14%
Free Cash Flow Margin	-16.50%	-28.57%	2.82%	-26.51%
EBITDA	-70.91	-65.73	4.79	-35.45
EBITDA Margin	-14.75%	-14.84%	1.21%	-14.63%
D&A For EBITDA	2.08	3.08	4.8	4.89
EBIT	-72.99	-68.81	-0.01	-40.34
EBIT Margin	-15.18%	-15.53%	-0.00%	-16.64%